A vs B [Design Issues]

posted by mittyri – Russia, 2020-02-03 21:05 (261 d 22:21 ago) – Posting: # 21136
Views: 1,658

Hi John,

citing our Hero:

If one is really interested in λz and has no SD-phase in the study, sampling should continue until concentrations from previous doses are washed out – I would expect any estimate within the MD-profile to be biased towards faster elimination.

» I have seen both designs but I (and my former bosses) prefer method A. The only drawback I see from A is it takes longer time.

why does A take longer time?

Edit: Changed to internal link; see also this post #7[Helmut]

Kind regards,

Complete thread:

 Admin contact
21,176 posts in 4,413 threads, 1,475 registered users;
online 7 (0 registered, 7 guests [including 5 identified bots]).
Forum time: Thursday 20:27 CEST (Europe/Vienna)

It is not so much that I have confidence in scientists being right,
but that I have so much in nonscientists being wrong.    Isaac Asimov

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz